Early recovery of the platelet count after decitabine-based induction chemotherapy is a prognostic marker of superior response in elderly patients with newly diagnosed acute myeloid leukaemia

BACKGROUND: Definite prognostic clinical factors of benefit for decitabine-based induction chemotherapy in elderly patients newly diagnosed with acute myeloid leukaemia (AML) are not identified. This study was designed to explore the potential biomarker, especially regeneration of haematopoiesis, of...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jiayu, Zhao, Huihui, Hong, Ming, Zhu, Han, Zhu, Yu, Lian, Yun, Li, Shan, Li, Jianyong, Qian, Sixuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299938/
https://www.ncbi.nlm.nih.gov/pubmed/30567513
http://dx.doi.org/10.1186/s12885-018-5160-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299938/
https://www.ncbi.nlm.nih.gov/pubmed/30567513
http://dx.doi.org/10.1186/s12885-018-5160-5

Ejemplares similares